Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Question for the Pharma Savvy
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(394)
•••
Comment by Tarbabyon Jun 13, 2024 2:16am
210 Views
Post# 36086412

RE:Question for the Pharma Savvy

RE:Question for the Pharma SavvyTLT was basically a one trick pony until very recently.
Investors got tired of waiting for the bladder cancer trial to be completed..and just lost patience.  So the stock just languished.

Now suddenly we get a smorgasbord of almost miraculous treatments like... vaccine for blood cancers..Radiation activated Rudivar to kill lung and other cancer...Ru bcg combo for bladder cancer...Rutherrin plus chemo combination for all
cancers...vaccine against all or most viruses like herpes bird flu covid.etc
And such easy to do treatments..just iv plus xrays plus injections and inocculations..
Not months and months of suffering agonizing chemo or high intensity radiation..etc.
If this news came from a big pharma their stock price would be the biggest price gainer in the whole world...!!!
WAKE UP INVESTORS...this has to be real.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities